PMS34 COST-UTILITY ANALYSIS OF DENOSUMAB VERSUS RALOXIFENE FOR TREATING OSTEOPOROSIS IN POST-MENOPAUSAL WOMEN IN THE UNITED STATES
Keyword(s):
Keyword(s):
2019 ◽
Vol 45
(7)
◽
pp. 927-938
◽
Keyword(s):
Keyword(s):
2010 ◽
Vol 95
(4)
◽
pp. 1672-1680
◽
Keyword(s):